换一批Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.
第一作者：
Myong Cheol,Lim
第一单位：
Cancer Healthcare Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.;Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.;Center for Clinical Trials, Research Institute and Hospital, National Cancer Center, Goyang, Korea.;Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌症医护设施(Cancer Care Facilities);卡铂(Carboplatin);化学疗法, 辅助(Chemotherapy, Adjuvant);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤分期(Neoplasm Staging);肿瘤, 残余(Neoplasm, Residual);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);诊疗准则(主题)(Practice Guidelines as Topic);回顾性研究(Retrospective Studies);存活率(Survival Rate)
DOI
10.3802/jgo.2017.28.e48
PMID
28541636
发布时间
2018-11-13
- 浏览9
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
